Peptide And Oligonucleotide CDMO Market Size, Share & Trends Report

Peptide And Oligonucleotide CDMO Market Size, Share & Trends Analysis Report By Product (Peptides, Oligonucleotides), By Service Type, By End Use (Pharmaceutical Companies, Biopharmaceutical Companies), By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68040-182-4
  • Number of Pages: 195
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Peptides
    • Oligonucleotides
  • Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Contract Development
    • Contract Manufacturing
  • Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Others
  • Peptide and Oligonucleotide CDMO Market, By Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • North America Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • North America Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • U.S. Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • U.S. Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • U.S. Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Canada Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Canada Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Canada Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Europe Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Europe Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Europe Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • UK Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • UK Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • UK Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Germany Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Germany Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Germany Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • France Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • France Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • France Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Italy Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Italy Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Italy Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Spain Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Spain Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Spain Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Denmark Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Denmark Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Denmark Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Sweden Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Sweden Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Sweden Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Norway Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Norway Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Norway Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Asia Pacific Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Asia Pacific Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Asia Pacific Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Japan Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Japan Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Japan Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • China Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • China Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • China Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • India Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • India Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • India Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Australia Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Australia Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Australia Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Thailand Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Thailand Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Thailand Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • South Korea Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • South Korea Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • South Korea Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Latin America Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Latin America Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Latin America Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Brazil Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Brazil Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Brazil Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Mexico Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Mexico Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Mexico Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Argentina Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Argentina Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Argentina Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Middle East & Africa Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Middle East & Africa Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Middle East & Africa Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • South Africa Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • South Africa Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • South Africa Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Saudi Arabia Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Saudi Arabia Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Saudi Arabia Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • UAE Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • UAE Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • UAE Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others
    • Kuwait Peptide and Oligonucleotide CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      • Peptides
      • Oligonucleotides
    • Kuwait Peptide and Oligonucleotide CDMO Market, By Service Type Outlook (Revenue, USD Million, 2018 - 2030)
      • Contract Development
      • Contract Manufacturing
    • Kuwait Peptide and Oligonucleotide CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon